Trial Profile
Phase I trial of VTX 1463 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Jan 2010
Price :
$35
*
At a glance
- Drugs VTX 1463 (Primary)
- Indications Allergic rhinitis
- Focus Adverse reactions; Pharmacokinetics
- 13 Jan 2010 Status changed from recruiting to completed as reported in a VentiRx Pharmaceuticals media release.
- 23 Apr 2009 New trial record.